Kezar Life Sciences Inc.

10/17/2024 | Press release | Distributed by Public on 10/17/2024 06:47

Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.